- Home
- CRBU vs PDEX Comparison
CRBU vs PDEX Comparison
Compare CRBU & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- PDEX
- Stock Information
- Founded
- CRBU 2011
- PDEX 1978
- Country
- CRBU United States
- PDEX United States
- Employees
- CRBU N/A
- PDEX N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- PDEX Medical/Dental Instruments
- Sector
- CRBU Health Care
- PDEX Health Care
- Exchange
- CRBU Nasdaq
- PDEX Nasdaq
- Market Cap
- CRBU 165.8M
- PDEX 152.3M
- IPO Year
- CRBU 2021
- PDEX N/A
- Fundamental
- Price
- CRBU $1.78
- PDEX $34.76
- Analyst Decision
- CRBU Strong Buy
- PDEX Strong Buy
- Analyst Count
- CRBU 3
- PDEX 1
- Target Price
- CRBU $6.67
- PDEX $56.00
- AVG Volume (30 Days)
- CRBU 729.3K
- PDEX 37.7K
- Earning Date
- CRBU 11-05-2025
- PDEX 10-30-2025
- Dividend Yield
- CRBU N/A
- PDEX N/A
- EPS Growth
- CRBU N/A
- PDEX 345.00
- EPS
- CRBU N/A
- PDEX 2.67
- Revenue
- CRBU $9,121,000.00
- PDEX $66,593,000.00
- Revenue This Year
- CRBU $9.23
- PDEX $7.22
- Revenue Next Year
- CRBU N/A
- PDEX N/A
- P/E Ratio
- CRBU N/A
- PDEX $12.89
- Revenue Growth
- CRBU N/A
- PDEX 23.68
- 52 Week Low
- CRBU $0.66
- PDEX $25.01
- 52 Week High
- CRBU $3.00
- PDEX $70.26
- Technical
- Relative Strength Index (RSI)
- CRBU 46.16
- PDEX 37.10
- Support Level
- CRBU $1.72
- PDEX $31.72
- Resistance Level
- CRBU $1.94
- PDEX $35.00
- Average True Range (ATR)
- CRBU 0.11
- PDEX 2.09
- MACD
- CRBU -0.01
- PDEX -0.73
- Stochastic Oscillator
- CRBU 26.53
- PDEX 18.89
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.